Experimental orthotopic prostate tumor in nude mice: Techniques for local cell inoculation and three-dimensional ultrasound monitoring

Urologic Oncology: Seminars and Original Investigations

Volumn 30, Issue 3, 2012, Pages 330-338

  Saar, Matthias ^a   Körbel, Christina ^a   Jung, Volker ^a   Suttmann, Henrik ^b   Grobholz, Rainer ^a   Stöckle, Michael ^a   Unteregger, Gerhard ^a   Menger, Michael D ^a   Kamradt, Jörn ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Urologikum Hamburg   (Germany)

Author keywords

Orthotopic tumor growth; Prostate cancer; Ultrasound; Xenograft model

Indexed keywords

MATRIGEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; CANCER CELL; CANCER GROWTH; CELL STRAIN; CONTROLLED STUDY; HISTOLOGY; IN VIVO STUDY; INOCULATION; MALE; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; NUDE MOUSE; ORTHOTOPIC PROSTATE CANCER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CAPSULE RECOIL; PROSTATE CAPSULE RUPTURE; PROSTATE DISEASE; THREE DIMENSIONAL IMAGING; TUMOR ENGRAFTMENT; ULTRASOUND;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; COLLAGEN; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; HUMANS; IMAGING, THREE-DIMENSIONAL; LAMININ; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PROSTATIC NEOPLASMS; PROTEOGLYCANS; ULTRASONOGRAPHY;

EID: 84860293649     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2010.02.014     Document Type: Article

References (39)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
2. Carter H.B., Coffey D.S. The prostate: An increasing medical problem. Prostate 1990, 16:39-48.
3. Peehl D.M. Primary cell cultures as models of prostate cancer development. Endocr Relat Cancer 2005, 12:19-47.
4. Pienta K.J., Abate-Shen C., Agus D.G., et al. The current state of preclinical prostate cancer animal models. Prostate 2008, 68:629-639.
5. Fu X., Herrera H., Hoffman R.M. Orthotopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically intact tissue. Int J Cancer 1992, 52:987-990.
6. Pettaway C.A., Pathak S., Greene G., et al. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 1996, 2:1627-1636.
7. An Z., Wang X., Geller J., et al. Surgical orthotopic implantation allows high lung and lymph node metastatic expression of human prostate carcinoma cell line PC-3 in nude mice. Prostate 1998, 34:169-174.
8. Sinowatz F., Amselgruber W., Plendl J., et al. Normal development of testis and male accessory sex organs. Monograph on the pathobiology of the aging mouse 1995, Vol. I:406-430. ILSI Press, Washington. U. Mohr, D.L. Dungworth, C.C. Capen (Eds.).
9. Sugimura Y., Cunha G.R., Donjacour A.A. Morphogenesis of ductal networks in the mouse prostate. Biol Reprod 1986, 34:961-971.
10. Tuomela J.M., Valta M.P., Väänänen K., et al. Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice. BMC Cancer 2008, 81:1-12.
11. Chan E., Patel A., Heston W., et al. Mouse orthotopic models for bladder cancer research. BJU Int 2009, 104:1286-1291.
12. Kusaka N., Nasu Y., Arata R., et al. Transrectal ultrasound for monitoring murine orthotopic prostate tumor. Prostate 2001, 47:118-124.
13. Graeser R., Chung D.A., Esser N., et al. Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP). Int J Cancer 2008, 122:1145-1154.
14. Nastiuk K.L., Liu H., Hamamura M., et al. In vivo MRI volumetric measurement of prostate regression and growth in mice. BMC Urol 2007, 24:7-12.
15. Wirtzfeld L.A., Wu G., Bygrave M., et al. A new three-dimensional ultrasound microimaging technology for preclinical studies using a transgenic prostate cancer mouse model. Cancer Res 2005, 65:6337-6345.
16. Bex A., Wullich B., Endris V., et al. Comparison of the malignant phenotype and genotype of the human androgen-independent cell line DU 145 and a subline derived from metastasis after orthotopic implantation in nude mice. Cancer Genet Cytogenet 2001, 124:98-104.
17. Lensch R., Götz C., Andres C., et al. Comprehensive genotypic analysis of human prostate cancer cell lines and sublines derived from metastases after orthotopic implantation in nude mice. Int J Oncol 2002, 21:695-706.
18. Kamradt J., Jung V., Wahrheit K., et al. Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based array CGH. PLoS ONE 2007, 2:e769.
19. Kleinman H.K., McGarvey M.L., Hassell J.R., et al. Basement membrane complexes with biological activity. Biochemistry 1986, 25:312-318.
20. Fridman R., Kibbey M.C., Royce L.S., et al. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after co-injection with matrigel. J Natl Cancer Inst 1991, 83:769-774.
21. Foster F.S., Zhang M.Y., Zou Y.Q., et al. A new ultrasound instrument for in vivo micro-imaging of mice. Ultrasound Med Biol 2002, 28:1165-1172.
22. Fenster A., Downey D.B., Cardinal H.N. Three-dimensional ultrasound imaging. Phys Med Biol 2001, 46:67-99.
23. Tomayko M.M., Reynolds C.P. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989, 24:148-154.
24. Sato N., Gleave M.E., Bruchovsky N., et al. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice. Cancer Res 1997, 57:1584-1589.
25. Kollmar O., Schilling M.K., Menger M.D. Experimental liver metastasis: Standards for local cell implantation to study isolated tumor growth in mice. Clin Exp Metastasis 2004, 21:453-460.
26. Koshida K., Konaka H., Imao T., et al. Comparison of two in vivo models for prostate cancer: Orthotopic and intratesticular inoculation of LNCaP or PC-3 cells. Int J Urol 2004, 11:1114-1121.
27. Stephenson R.A., Dinney C.P., Gohji K., et al. Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 1992, 84:951-957.
28. Rembrink K., Romijn J.C., van der Kwast T.H., et al. Orthotopic implantation of human prostate cancer cell lines: A clinically relevant animal model for metastatic prostate cancer. Prostate 1997, 31:168-174.
29. Bastide C., Bagnis C., Mannoni P., et al. A NOD/SCID mouse model to study human prostate cancer. Prostate Cancer Prostatic Dis 2002, 5:311-315.
30. O'Reilly M.S., Boehm T., Shing Y., et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-285.
31. Gohongi T., Fukumura D., Boucher Y., et al. Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: Involvement of transforming growth factor β1. Nat Med 1999, 5:1203-1208.
32. Shankar S., Chen Q., Ganapathy S., et al. Diallyl trisulfide increases the effectiveness of TRIAL and inhibits prostate cancer growth in an orthotopic model: Molecular mechanisms. Mol Cancer Ther 2008, 7:2328-2338.
33. Kovar L.K., Johnson M.A., Volcheck W.M., et al. A. Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Am J Pathol 2006, 169:1415-1426.
34. Freytag S.O., Paielli D., Wing M., et al. Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model. Int J Radiat Oncol Biol Phys 2002, 54:873-885.
35. Lim D.J., Liu X.I., Sutkowski D.M., et al. Growth of an androgen-sensitive human prostate cancer cell line, LNCaP, in nude mice. Prostate 1993, 22:109-118.
36. Pretlow T.G., Delmoro C.M., Dilley G.G., et al. Transplantation of human prostatic carcinoma into nude mice in Matrigel. Cancer Res 1991, 51:3814-3817.
37. Kleinman H.K., Fridman R., Kanemoto T., et al. Role of basement membrane and laminin in metastases and tumor growth. Proc Am Assoc Cancer Res 1990, 31:490-491.
38. Wu G., Wang L., Yu L., et al. The use of three-dimensional ultrasound micro-imaging to monitor prostate tumor development in a transgenic prostate cancer mouse model. Tohoku J Exp Med 2005, 207:181-189.
39. Weissleder R. Scaling down imaging: Molecular mapping of cancer in mice. Nat Rev Cancer 2002, 2:11-18.